Viemed Healthcare, Inc.
NASDAQ:VMDMedical - Devices
Healthcare
$8.61 +0.68%
+$0.07 today
- Market cap
- $326.26M
- Beta
- 1.13
- P/E (TTM)
- 27.4
- EPS (TTM)
- $0.39
52W Low $5.93High $10.68
Volume 0.17M
Average 0.26M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
$51.92M
FY 2025 · Annual
+32.8% YoYInvesting Cash Flow
-$50.17M
FY 2025 · Annual
Financing Cash Flow
-$5.79M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY 2021 Dec 2021 | FY 2022 Dec 2022 | FY 2023 Dec 2023 | FY 2024 Dec 2024 | FY 2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 9.13M | 6.22M | 10.24M | 11.41M | 14.93M |
| Depreciation & Amortization | 11.31M | 15.63M | 21.86M | 25.37M | 28.61M |
| Deferred Income Tax | 3.88M | 1.75M | (1.44M) | (3.84M) | 3.11M |
| Stock-Based Compensation | 5.15M | 5.2M | 5.85M | 6.29M | 9.13M |
| Change in Working Capital | (13.56M) | (10.14M) | 7.78M | 355K | (2.3M) |
| Accounts Receivables | (7.35M) | (12.57M) | (1.08M) | (6.07M) | 1.16M |
| Inventory | (212K) | 301K | (480.66K) | 574K | 59K |
| Accounts Payables | 133K | (318K) | (874.75K) | 359K | 479K |
| Other Working Capital | (6.14M) | 2.45M | 10.21M | 5.5M | (4M) |
| Other Non-Cash Items | 6.58M | 9.08M | 921K | (488K) | (1.57M) |
| Operating Cash Flow | 22.49M | 27.75M | 45.21M | 39.09M | 51.92M |
| Capital Expenditures | (19.74M) | (22.9M) | (26.09M) | (37.77M) | (39.99M) |
| Acquisitions (Net) | (599K) | (141K) | (28.59M) | (3M) | (26.33M) |
| Purchases of Investments | (593.73K) | (2M) | 0 | 0 | 0 |
| Sales of Investments | 593.73K | 0 | 0 | 750K | 0 |
| Other Investing Activities | 596K | 1.06M | 2.57M | 9.32M | 16.15M |
| Investing Cash Flow | (19.75M) | (23.98M) | (52.11M) | (30.7M) | (50.17M) |
| Debt Repayment | (4M) | (5.84M) | 2.12M | (3.41M) | 8.15M |
| Common Stock Issued | 0 | 0 | 0 | 0 | 1.44M |
| Common Stock Repurchased | (1.43M) | (9.71M) | (594K) | (1.07M) | (13.23M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 112K | 283K | 1.3M | 789K | (2.16M) |
| Financing Cash Flow | (5.32M) | (15.27M) | 2.83M | (3.69M) | (5.79M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (2.57M) | (11.49M) | (4.08M) | 4.7M | (4.04M) |
| Free Cash Flow | 2.75M | 4.85M | 19.12M | 1.32M | 11.93M |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income$14.9M
+ D&A$28.6M
+ Stock-Based Comp$9.1M
+ Deferred Tax$3.1M
- Working Capital-$2.3M
- Other Non-Cash-$1.6M
= Operating Cash Flow$51.9M
- Capex-$40.0M
= Free Cash Flow$11.9M
Analysis
FY2025 free cash flow is $11.9M. FCF conversion is 79.9% of net income. Operating cash flow was $51.9M, with capex of -$40.0M. The largest bridge item is Capex at -$40.0M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 4, 2026 | |
| 10-Q | Quarterly report | Nov 4, 2026 | |
| SC 13D/A | SC 13D/A filing | Sep 24, 2026 | |
| 8-K | Current report | Aug 20, 2026 | |
| 4 | Statement of changes in beneficial ownership | Aug 19, 2026 |
Does VMD generate free cash flow?
Viemed Healthcare, Inc. (VMD) generated $11.93M of free cash flow in fiscal 2025.
How much operating cash flow does VMD produce?
Operating cash flow was $51.92M, before capital expenditures of $39.98M.
Continue the stock analysis
Jump to another research area for this company.